Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

WisdomInterface

Overcoming upstream and downstream process barriers for large-scale AAV production

In this webinar, Overcoming upstream and downstream process barriers for large-scale AAV production, speakers from Encoded Therapeutics and Thermo Fisher Scientific will share insights and strategies to optimize your AAV manufacturing process to accelerate the development of safe and effective gene therapies.

Key takeaways:

  • Find out about an end-to-end solution for development and commercial production of AAV
  • Learn how new products and technologies can help address production efficiency, regulatory concerns, and scale-up of AAV production protocols
  • Understand how critical manufacturing challenges are currently being addressed by gene therapy developers
SUBSCRIBE

    Subscribe for more insights



    By completing and submitting this form, you understand and agree to WisdomInterface processing your acquired contact information as described in our privacy policy.

    No spam, we promise. You can update your email preference or unsubscribe at any time and we'll never share your details without your permission.

      Subscribe for more insights



      By completing and submitting this form, you understand and agree to WisdomInterface processing your acquired contact information as described in our privacy policy.

      No spam, we promise. You can update your email preference or unsubscribe at any time and we'll never share your details without your permission.